Cormedix
CRMD
$5.17
Share price
-4.44%
Change (1 day)
-2.45%
Change (1 year)
Categories
Cormedix (CRMD) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $11.91 M
According to Cormedix's latest financial reports the company's total liabilities are $11.91 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Cormedix - Total liabilities on balance sheet (from 2009 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $11.91 M | 70.77% |
| 2022-12-31 | $6.97 M | 13.52% |
| 2021-12-31 | $6.14 M | 20.89% |
| 2020-12-31 | $5.08 M | -12.77% |
| 2019-12-31 | $5.82 M | -58.03% |
| 2018-12-31 | $13.89 M | 121.89% |
| 2017-12-31 | $6.26 M | 53% |
| 2016-12-31 | $4.09 M | 32.41% |
| 2015-12-31 | $3.09 M | 111.18% |
| 2014-12-31 | $1.46 M | -79.07% |
| 2013-12-31 | $6.99 M | 369.57% |
| 2012-12-31 | $1.48 M | 21.57% |
| 2011-12-31 | $1.22 M | -23.11% |
| 2010-12-31 | $1.59 M | -90.6% |
| 2009-12-31 | $16.93 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | $26.94 B | 225,962.51% | 🇺🇸 USA |
 Utah Medical Products UTMD | $7.14 M | -40.05% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $1.17 B | 9,750.22% | 🇺🇸 USA |